Managing and Monitoring Infections and Neurological Toxicities in Patients Receiving Bispecific Therapies

Opinion
Video

Dr. Mohan discusses with Nurse Goff and Nurse Brigle the prevention and management of infections and neurological toxicities in patients receiving bispecific therapies, with a particular focus on the unique considerations of talquetamab targeting GPRC5D.

Video content above is prompted by the following:

  • How do you approach the prevention and management of infections in patients receiving bispecific therapies, particularly considering the unique target of talquetamab (GPRC5D)?
  • What are your protocols for monitoring and managing neurological toxicities in patients receiving bispecific therapies?
    • Are there any specific considerations for talquetamab?

Newsletter

Stay up to date on recent advances in oncology nursing and patient care.

Recent Videos
Image of a woman with gray hair on a light blue background
2 experts are featured in this series.
2 experts are featured in this series.
Photo of a private infusion bay with a large screen for video calls
2 experts are featured in this series.
2 experts are featured in this series.
Photo of a man wearing scrubs in front of a blue background
2 experts are featured in this series.
2 experts are featured in this series.
Photo of a woman with blonde hair wearing a denim jacket in front of a blue background
Related Content